Skip to content

Effect of airbag pressure monitoring in radial artery patency hemostasis: a randomized controlled trial

Effect of airbag pressure monitoring in radial artery patency hemostasis: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088258
Enrollment
Unknown
Registered
2024-08-14
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Airbag pressure monitoring method:Based on the airbag-type radial artery compressor, a pressure gauge is connected to accurately display the airbag pressure. 1. Initial Inflation Method: At the end of

Sponsors

Nanjing Lishui District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old or over and less than 80 years old; 2. Patients undergoing coronary angiography in the Department of Cardiology; 3. Patients with clear consciousness and certain ability to understand and express; 4. Patients who are willing to participate in the study and provide written informed consent; 5. Use of antiplatelet drugs: aspirin enteric-coated tablet 300mg+ ticagrelor tablet 180mg/ Clopidogrel bisulfate tablet 300mg one day before surgery; On the day of surgery, aspirin enteric-coated tablet 100mg+ ticagrelor tablet 90mg/ Clopidogrel bisulfate tablet 75mg.

Exclusion criteria

Exclusion criteria: 1. Patients with upper limb disability or deformity; 2. Patients with local skin or tissue edema or infection; 3. Patients with abnormal coagulation function or severe complications who have had two or more ipsilateral radial artery puncture; 4. The puncture point is not 1-2cm below the palm stripe.

Design outcomes

Primary

MeasureTime frame
Incidence of 24-hour RAO;

Secondary

MeasureTime frame
Incidence of vascular complications;Bleeding complication rate;convenience ;

Countries

China

Contacts

Public ContactZou Lan

Nanjing Lishui District People's Hospital

zoulan@lsrmyy.com+86 139 1336 0716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 6, 2026